Insider Transactions in Q4 2024 at Natures Sunshine Products Inc (NATR)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 11
2024
|
Steven J. Fasching Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,869
+50.0%
|
$48,773
$17.43 P/Share
|
|
Oct 15
2024
|
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
2,300
-3.46%
|
$29,900
$13.02 P/Share
|
|
Oct 14
2024
|
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,300
-1.92%
|
$16,900
$13.12 P/Share
|
|
Oct 11
2024
|
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,580
-2.28%
|
$20,540
$13.37 P/Share
|
|
Oct 10
2024
|
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
3,000
-4.15%
|
$39,000
$13.39 P/Share
|
|
Oct 09
2024
|
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,816
-2.45%
|
$23,608
$13.36 P/Share
|
|
Oct 08
2024
|
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,800
-2.37%
|
$23,400
$13.13 P/Share
|
|
Oct 01
2024
|
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,399
-1.81%
|
$18,187
$13.54 P/Share
|